Prospective Long-Term Follow-up after First-Line Subcutaneous Cladribine Treatment in Patients with Hairy Cell Leukemia. a Study of the SAKK (Swiss Group for Clinical Cancer Research)

Conclusion: Long-term overall survival in HCL patients treated with sc Cld was excellent and comparable to studies using iv Cld. Despite the long follow-up, sc Cld had a curative potential and relapses requiring re-treatment were observed only in a minority of patients. Secondary malignancies were predominantly non-hematological. These data indicate that patients need to be followed carefully with a special focus on secondary malignancies.DisclosuresChalandon: Roche: Membership on an entity's Board of Directors or advisory committees, Other: Travel costs.

Source: Blood - November 21, 2018 Category: Hematology Authors: Benz, R. A., Arn, K., Andres, M., Pabst, T., Novak, U., Hitz, F., Zenhausern, R., Chalandon, Y., Mey, U., Blum, S., Rauch, D., Nettekoven, W., Cantoni, N., Bargetzi, M., O'Meara, A., Lohri, A., Berardi, S., Li, Q., Stussi, G. Tags: 623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma-Clinical Studies: Poster II Source Type: research